EGeen

About EGeen

EGeen International, Inc. is a global contract research organization (CRO) that provides clinical trial management services for biotech and pharmaceutical companies. The company focuses on advancing drug development through cost-effective and high-quality clinical trials. Its services cover the full range of clinical trial needs, including rapid patient recruitment, clinical trial design, management, monitoring, regulatory affairs, and data analysis. EGeen is known for its Generic Drug Development (GDD) Program, which utilizes the European trial environment to support worldwide filings. The firm has experience in various therapeutic areas, such as oncology, cardiology, neurology, and gastroenterology.

Founded by Dr. Kalev Kask, who served as the founding CEO, EGeen grew into a global clinical research organization. Dr. Kask has a background that includes postgraduate training at Stockholm University, Stanford University, and the Max-Planck Institute for Medical Research. The current CEO is Rauno Oja, who holds an MBA from Tartu University and has led the company's operational and business development for over a decade. EGeen is headquartered in Mountain View, California, and maintains an extensive clinical operations network in Eastern Europe.